PT1347753E - Composicao topica e metodo para o tratamento da incontinencia urinaria de stress - Google Patents

Composicao topica e metodo para o tratamento da incontinencia urinaria de stress

Info

Publication number
PT1347753E
PT1347753E PT01270327T PT01270327T PT1347753E PT 1347753 E PT1347753 E PT 1347753E PT 01270327 T PT01270327 T PT 01270327T PT 01270327 T PT01270327 T PT 01270327T PT 1347753 E PT1347753 E PT 1347753E
Authority
PT
Portugal
Prior art keywords
stress
treatment
urinary incontinence
topical composition
composition
Prior art date
Application number
PT01270327T
Other languages
English (en)
Inventor
Michael G Wyllie
Leaker Brian
Original Assignee
Plethora Solutions Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Plethora Solutions Ltd filed Critical Plethora Solutions Ltd
Publication of PT1347753E publication Critical patent/PT1347753E/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0034Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/10Drugs for disorders of the urinary system of the bladder

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gynecology & Obstetrics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Reproductive Health (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
PT01270327T 2000-12-15 2001-12-17 Composicao topica e metodo para o tratamento da incontinencia urinaria de stress PT1347753E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0030580.5A GB0030580D0 (en) 2000-12-15 2000-12-15 Composition and method

Publications (1)

Publication Number Publication Date
PT1347753E true PT1347753E (pt) 2006-07-31

Family

ID=9905129

Family Applications (1)

Application Number Title Priority Date Filing Date
PT01270327T PT1347753E (pt) 2000-12-15 2001-12-17 Composicao topica e metodo para o tratamento da incontinencia urinaria de stress

Country Status (13)

Country Link
US (2) US20040044082A1 (pt)
EP (1) EP1347753B3 (pt)
JP (1) JP2004518646A (pt)
KR (1) KR100879656B1 (pt)
AT (1) ATE319441T1 (pt)
AU (2) AU2002222221B2 (pt)
CA (1) CA2431519C (pt)
DE (1) DE60117685T3 (pt)
DK (1) DK1347753T5 (pt)
ES (1) ES2260160T7 (pt)
GB (1) GB0030580D0 (pt)
PT (1) PT1347753E (pt)
WO (1) WO2002047676A1 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1792629A4 (en) 2004-08-25 2010-08-25 Takeda Pharmaceutical PREVENTIVE / REMEDY AGENTS FOR INCONTINENCE OF STRESS AND SELECETING METHOD THEREOF
US7745665B2 (en) 2007-06-04 2010-06-29 Auspex Pharmaceuticals, Inc. Substituted phenethylamines

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19514579A1 (de) * 1995-04-20 1996-10-24 Boehringer Ingelheim Kg Verwendung von alpha¶1¶¶L¶-Agonisten zur Behandlung der Harninkontinenz
US5610174A (en) * 1995-06-02 1997-03-11 Synaptic Pharmaceutical Corporation Use of α1A -selective adrenoceptor agonists for the treatment of urinary incontinence
US5861431A (en) * 1995-06-07 1999-01-19 Iotek, Inc. Incontinence treatment
US5789442A (en) * 1996-01-18 1998-08-04 Schering Aktiengesellschaft Treatment of urinary incontinence with nitric oxide synthase substrates and/or nitric oxide donors alone or in combination with estrogen or progesterone and/or other agents
WO1998011888A1 (en) 1996-09-19 1998-03-26 American Home Products Corporation Method of treating urinary incontinence
ES2259806T5 (es) * 1996-12-23 2009-05-01 S.L.A. Pharma Ag Composicion farmaceutica para tratar la incontinencia fecal.
US6323231B1 (en) * 2000-02-17 2001-11-27 Abbott Laboratories Use of α1A adrenoceptor agonists with α1B and α1D antagonism for the treatment of stress urinary incontinence

Also Published As

Publication number Publication date
JP2004518646A (ja) 2004-06-24
EP1347753B3 (en) 2009-08-12
GB0030580D0 (en) 2001-01-31
AU2002222221B2 (en) 2006-11-30
EP1347753B1 (en) 2006-03-08
DK1347753T5 (da) 2010-01-11
DE60117685T3 (de) 2010-02-18
CA2431519C (en) 2010-05-04
ATE319441T1 (de) 2006-03-15
ES2260160T3 (es) 2006-11-01
DE60117685T2 (de) 2006-09-21
US20040044082A1 (en) 2004-03-04
CA2431519A1 (en) 2002-06-20
WO2002047676A1 (en) 2002-06-20
AU2222102A (en) 2002-06-24
ES2260160T7 (es) 2010-03-31
EP1347753A1 (en) 2003-10-01
KR100879656B1 (ko) 2009-01-20
US20100239670A1 (en) 2010-09-23
KR20030069184A (ko) 2003-08-25
DE60117685D1 (de) 2006-05-04
DK1347753T3 (da) 2006-07-10

Similar Documents

Publication Publication Date Title
EA200001044A3 (ru) Соединения для лечения женской сексуальной дисфункции
WO2002041883A3 (en) As-needed administration of tricyclic and other non-sri antidepressant drugs to treat premature ejaculation
MY144292A (en) Method of reducing oral tissue inflammation using magnolia extract
BR0110420A (pt) Agonistas muscarìnicos
PT1227820E (pt) Acidos oligossacarido-aldonicos e sua utilizacao topica
BR9808888A (pt) Formas de dosagem e método de melhorar disfunção erétil masculina
UA41989C2 (uk) Фармацевтична композиція у вигляді гелю для лікування захворювань шкіри та спосіб лікування інфікованої шкіри
IL138979A0 (en) Use of cannabinoids as anti-inflammatory agents
NO20044699L (no) Vaginalpleiesammensetning
BR0311939A (pt) composição farmacêutica, método para tratar inflamação em um mamìfero e uso de uma citocina protetora de tecido orgánico
ATE299740T1 (de) Kombination aus einem no-donor und einem antioxidans zur behanndlung sexueller störungen
AU2003241345A1 (en) Use of mastic and its components for the control of microbial infections
CY1106227T1 (el) Συνθεση για τη διευκολυνση του ανθρωπινου τοκετου
WO1999015165A1 (en) Topical non-steroidal anti-inflammatory drug composition
BRPI0208411B8 (pt) composto, composição farmacêutica tópica para tratamento profilático ou terapêutico de doenças sexualmente transmitidas em um paciente humano, e, uso de um composto
ES2125696T3 (es) Utilizacion del cloruro de tropsio para la produccion de una preparacion farmaceutica para el tratamiento de disfunciones vesicales.
HUP0202776A2 (hu) (+)-Tramadol, O-demetil-tramadol, (+)-O-demetil-tramadol, O-demetil-N-mono-demetil-tramadol, illetve (+)-O-demetil-N-mono-demetil-tramadol felhasználása vizeletinkontinencia kezelésére alkalmas gyógyszerkészítmény előállítására
RS50298B (sr) Direktno kompresibilna matrica za kontrolisano oslobađanje pojedinačnih dnevnih doza klaritromicina
PL402550A1 (pl) Dopochwowe kompozycje farmaceutyczne oraz zastosowanie zródla nadtlenku i bioadhezyjnego nosnika
BR0201974A (pt) Composição farmacêutica para tratamento de alterações do sono
PT1347753E (pt) Composicao topica e metodo para o tratamento da incontinencia urinaria de stress
EP1123692A3 (fr) Utilisation de dérivés de polyaminoacides pour traiter la séborrhée et les désordres cutanés associés
GEP20043231B (en) Resorcinol Composition
BR0209613A (pt) Composição para tratamento de dor em um mamìfero, e, método para redução ou eliminação de probabilidade de viciamento de um analgésico em um hospedeiro
HK1077008A1 (en) Composition for treating hemorrhoids